Engaging overdose survivors with SafeSpot to prevent repeat overdose
Official title: CE25-149 - Engaging Overdose Survivors with the SafeSpot Hotline for Secondary Overdose Prevention
Funded at Boston Medical Center · NIH-11422065 · Data updated 2026-11-12
A patient-facing program to help overdose survivors use a hotline and safety plan to reduce the chance of another overdose.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 30, 2025 |
| Project end | September 29, 2030 |
| Funding year | 2026 |
| Award (this year) | $699,573 |
| NIH project number | 5U01CE003822-02 |
| Project ID | NIH-11422065 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults who have survived an opioid overdose and are reachable to engage in safety planning and hotline use.
✕Less likely to help
Individuals without access to a phone or who are not willing to engage in safety planning may not benefit.
What this research studies
This project will develop and test a SafeSpot Overdose Safety Planning and Engagement (SOSPE) approach with survivors of opioid overdose. It involves practical steps like saving the SafeSpot number, practicing a call, and sending reminders to follow a safety plan. The study will partner with SafeSpot and a multidisciplinary team to tailor the intervention to survivors’ needs in real-world settings. If successful, it could provide a scalable way to support survivors and reduce repeat overdoses.
Why it matters
Potential benefit: If successful, survivors may have a clearer, more accessible way to get immediate help and reduce the risk of a repeat overdose.
How similar studies have gone: Previous hotline initiatives show promise but randomised testing of survivor-focused SOSPE-like approaches is limited.
Where this research is happening
-
Boston Medical Center
Boston, United States Active
Researchers
- Principal investigator: Walley, Alexander Yale — Boston Medical Center
- Study coordinator: Walley, Alexander Yale
Related research
Other NIH-funded projects on the same topics.
-
AI-supported heart failure diagnosis and management in Rwanda
Aiming to help people with suspected heart failure in Rwanda get faster, more accurate diagnoses and better care using AI-guided ultrasound and care protocols.
-
AI-assisted heart failure diagnosis in Rwanda using focused ultrasound
An NIH-funded project will test whether AI-enhanced, easy-to-use heart ultrasound can help non-experts diagnose and manage heart failure in Rwanda.
-
Improving access to integrated mental health care in under-resourced settings
A project to create and test practical measures that show how easily people can get integrated mental health care in resource-poor areas, with plans to use real-world data to guide better service delivery.
-
Gabapentin to help people with HIV reach and keep HIV control by reducing alcohol use
A clinical trial will test whether gabapentin can help people with HIV who drink heavily to reduce alcohol use and achieve better HIV viral load control.
-
TACTIC: Finding TB in people who use drugs through their social networks
This project tests a peer-led recruitment approach to find TB cases among people who use drugs and their close contacts to speed up testing and treatment.
-
HIV latency and reactivation: how LTR variability affects persistence and rebound
Researchers will study how different HIV LTR gene variations influence latency and reactivation, aiming to improve strategies to control persistent HIV reservoirs.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.